L-Valyl-L-prolylglycyl-L-prolyl-N5-(diaminomethylene)-L-ornithine

Metabolite details

Identifier

QVZKZDOWTVQTPL-OVWQWFNUSA-N

InChI Key

QVZKZDOWTVQTPL-OVWQWFNUSA-N

IUPAC name

(2S)-2-[[(2S)-1-[2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid

Preferred name

L-Valyl-L-prolylglycyl-L-prolyl-N5-(diaminomethylene)-L-ornithine

INN name

—

Synonym

L-Valyl-L-prolylglycyl-L-prolyl-L-Arginine

ChEBI

CHEBI:177519

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• G1_PBS_vs_G2_DSS